Human CD137 is a member of the tumor necrosis factor (TNF) receptor family and the homologue of murine 4-1BB. Recent studies have demonstrated that CD137 promotes accessory T cell activation, and regulates proliferation and survival of T lymphocytes. This study reports on the expression and function of CD137 in peripheral blood monocytes. While monocytes showed constitutive expression in 10 out of 18 healthy donors, CD137 was not expressed on resting T or B lymphocytes. Immobilized antibodies to CD137 markedly induced the production of IL-8 and TNF-α protein and mRNA, and led to inhibition of IL-10 expression by primary monocytes. Furthermore, cross-linking of CD137 on monocytes resulted in an increase of B lymphocyte apoptosis mediated by direct cell-cell contact of both cell populations. In conclusion, this study identified CD137 as a new receptor involved in monocyte activation by inducing a characteristic cytokine release profile. In addition, CD137 may play a role in monocyte-dependent control of B lymphocyte survival.
Introduction
CD137 is a member of the tumor necrosis factor (TNF) stimulus-specific manner (15) . CD137 is a potent costimulatory molecule to T lymphocytes in both man and mouse receptor family and the human homologue of mouse 4-1BB (1) . Similar to its mouse counterpart, human CD137 was first (16, 17) . Co-stimulation of T cells by CD137 has been reported to act dependently and independently of CD28 (18,19). In described as a gene induced by lymphocyte activation (ILA) (2) . Meanwhile, 4-1BB and ILA have been designated CD137 addition, CD137 regulates survival of T lymphocytes (17, 20) and amplifies tumor immunity in mice (21, 22) . The biological (3). As with other members of the TNF receptor family, human CD137 is located on chromosome 1p36 (4).
functions of human and mouse CD137 may differ since only the murine protein binds to laminin in addition to the specific The TNF receptor family consists of a growing number of type I transmembrane proteins such as TNF receptor I and ligand (23) . Recently, the association and usage of TNF receptor-associated factors (TRAF) for signaling has been II, the low-affinity nerve growth factor receptor, CD27, CD30, CD40, CD95, DR-3, DR-4, DR-5, DR-6, OX-40, and some viral shown for both human and mouse CD137. For both species, signal transduction via CD137 resulted in the activation of homologues (5-10) which are characterized by cysteine-rich repeats in the extracellular part. Most of these proteins are NFκB (24-26).
Monocytes and macrophages belong to the main effector involved in the regulation of activation and/or survival of cells (9). Many ligands for these receptors, among them the ligands cells of the immune system, being engaged in host defense mechanisms against pathogens and tumor cells or acting as for mouse and human CD137 (11,12), have been cloned and identify a family of mostly surface-bound type II transmemantigen-presenting cells (27) . Monocytes are known as a potent source of multiple biologically active molecules, such brane proteins with structural homology (13).
Human CD137 is present in immune cells such as as enzymes, plasma proteins and cytokines (28) . The objective of the present study was to determine whether activated T and B lymphocytes and monocytes, and a number of other cell lineages (14) . In addition, it is expressed in cells CD137 is expressed in peripheral blood cells. It is shown that CD137 is expressed by monocytes, but not by lymphocytes of mesenchymal origin in a differentiation-dependent and and is further induced during cell culture. Cross-linking of purified monocytes were added to culture plates. Cells were incubated at 37°C and 5% CO 2 . CD137 leads to monocyte activation as demonstrated by increased release of IL-8 and TNF-α, and by inhibition of In parallel, after 1.5 h of culture on immobilized antibodies, non-adherent cells of PBMC were removed by repeated (3 IL-10 production. Signaling through CD137 induces apoptosis of B lymphocytes by mechanisms requiring direct cell-cell times) vortexing of the whole-tissue culture plate and change of media. Remaining cells were lysed for RNA isolation contact between monocytes and B cells.
followed by cDNA synthesis and quantitative PCR for cytokine expression.
Methods

Immunohistochemistry Cell isolation and culture
Isolated monocytes were cultured on poly-L-lysineHuman peripheral blood mononuclear cells (PBMC) were coated glass slides, fixed by methanol-containing fixative prepared by Ficoll density gradient sedimentation according (Hemacolor; Merck, Darmstadt, Germany), and stained with to standard protocols. Isolated cells were used either directly antibodies to CD137, CD68 and isotype control antibody for flow cytometry analysis and isolation of total RNA or MOPC21. Endogenous peroxidase activity was blocked by cultured in RPMI 1640 medium supplemented with L-glutamphenylhydrazine (0.1% in PBS) and unspecific binding by ine, antibiotics and 10% FBS.
horse serum (5% in PBS). Primary antibodies were detected by biotinylated horse anti-mouse-IgG and streptavidinFlow cytometry peroxidase. For flow cytometry, cells (2-4ϫ10 5 cells each) were incubated Cytokine ELISA with phycoerythrin (PE)-labeled specific mAb to CD4 (MT310; Dako, Glostrup, Denmark), CD19 (HD37; Dako), CD14 (Tuek4;
The production of cytokines was determined in culture superCaltag, San Francisco, CA) and CD8 (3B5; Caltag). For natants by cytokine-specific ELISA. For IL-8 and IL-10, the detection of CD137 the unlabeled antibody M131, kindly Compact ELISA kit from CLB (Amsterdam, The Netherlands) provided by Immunex (Seattle, WA) was used. This antibody and for TNF-α a matched antibody pair from PharMingen and unlabeled MOPC21 (Sigma, St Louis, MO), as isotype (Hamburg, Germany) were used according to the manufaccontrol, were detected by FITC-labeled goat anti-mouse secturer's instructions. ondary antibodies. Cells were washed with staining buffer (PBS, 3% FBS and 0.1% sodium azide), incubated with RNA isolation propidium iodide (PI; 1 µg/ml) and analyzed on a FACScan Total RNA was isolated by the RNeasy isolation kit (Quiagen, (Becton Dickinson, Mountain View, CA). The software program Hilden, Germany) according to the manufacturer's instrucCellQuest 3.0.1 (Becton Dickinson) was used on a FACScan.
tions. Cells were lysed directly in culture plates and isolated The analysis of CD137 expression in subpopulations of PBMC RNA was resuspended in RNase-free water and stored at was performed after gating for viable cells by forward and -70°C until used in RT-PCR. side scatter and after exclusion of PI.
Quantitation of cytokine transcripts Purification of monocytes and B lymphocytes
The level of transcripts for IL-8 and TNF-α was determined For the enrichment of monocytes from Ficoll-isolated PBMC, by competitive PCR after reverse transcription of total RNA an antibody-mediated depletion technique was used with random hexamer primers as described (29) . We used (MACS Monocyte Isolation Kit; Miltenyi, Bergisch Gladbach, the multispecific competitor vector pQA1 (30) for quantitative Germany). Using a cocktail of MicroBeads-coupled antibod-PCR of IL-8 and TNF-α. To standardize the amount of cDNA, ies, lymphocytes, basophils, dendritic and NK cells were quantitative PCR reactions for β 2 -microglobulin were perremoved. Isolated monocytes had an average purity of 96%, formed for each sample. Briefly, PCR reactions with equal as analyzed by forward/side scatter and CD14 staining on aliquots of the diluted reverse transcription reaction containing flow cytometry. B cells were isolated by CD19-Dynabeads~4 0 ng cDNA equivalents and cytokine specific primers were (Dynal, Hamburg, Germany) and magnetic separation of added to serial 4-fold dilutions of known molarity (5ϫ10 6 to labeled cells with subsequent detachment of CD19 anti-7.5ϫ10 1 molecules) of the competitor. During co-amplification bodies, as provided by the manufacturer. Isolated cells were reactions, primers compete for annealing and amplification of Ͼ97% CD19 ϩ on flow cytometry.
of both competitor and cDNA resulting in PCR products Complete depletion of monocytes was achieved by staining easily separated by agarose gel electrophoresis. Equal band of PBMC with CD14-Dynabeads (Dynal) and removal of intensities of both fragments allow the quantitation of cDNA magnetic-labeled cells, according to the protocol provided transcripts relative to the competitor on densitometry. by the manufacturer. 
Analysis of cell-death/apoptosis Stimulation of monocytes by antibodies
Results
Expression of CD137 in human primary monocytes
Expression of CD137 in different cell types is known to be dependent on activation by the specific T or B cell receptor, or by proinflammatory cytokines (14-16). Earlier findings indicated that this is also true for human primary monocytes where expression of CD137 mRNA was only found after induction by stimuli such as phorbol esters and IL-1 (14). A first set of experiments in this study, however, demonstrated that monocytes can constitutively express CD137. CD137 protein expression was analyzed by flow cytometry of mononuclear cells directly after isolation from the peripheral blood of healthy donors. In 10 out of 18 donors, constitutive expression of CD137 on monocytes, ranging from 5 to 72%, was observed, whereas in all 18 samples we failed to detect CD137 in resting T or B cells (not shown). Time course experiments of monocytes on different surfaces, such as Teflon (Fig. 1A) or glass ( Fig. 1B and C), showed that CD137 is immediately up-regulated after beginning of cell cultures, presumably due to contact-mediated mechanisms. After cul- revealed CD14 ϩ monocytes as the only cell population expressing CD137. This was further confirmed by immunohistochemistry with antibodies to CD137 and CD68 (not shown). Supernatants were taken at different time points and analyzed for monocyte-derived cytokines by ELISA. Owing to significant donor-dependent variations in absolute cytokine levels, one representative experiment is shown in Fig. 3 (A-C). Cross-linking of CD137 by immobilized specific antibodies induced IL-8 protein in peripheral monocytes 3.8-fold (mean of four experiments) at the initial phase of culture after 2.5 h (Fig. 3A) . The overall expression of IL-8 increased with time in culture, possibly due to non-specific activation induced by in marked up-regulation of TNF-α protein, compared to control Constant amounts (40 ng) of target cDNA were co-amplified with antibodies ( Fig. 3B) . After 2.5 h of culture, TNF-α was induced different amounts of competitor cDNA, ranging from 1.25ϫ10 6 copies 2.1-fold (mean of four experiments). A similar increase of (dilution 2) to 4.9ϫ10 3 copies (dilution 6). Equal amounts of target 1.6-fold in TNF-α protein was also found after 6 h of culture.
and competitor cDNA, as determined by densitometric analysis, were used to calculate the amounts of IL-8 and TNF-α transcripts. Arrows
Enhanced TNF-α production after anti-CD137 was maximal indicate the points of equivalence between target and competitor after overnight culture (4.3-fold, mean of five experiments).
cDNA (ratio of target:competitor cDNA ϭ 1).
To prove that monocytes were the source of the increased levels of TNF-α and IL-8 induced by cross-linking of CD137, these experiments were repeated using purified primary monocytes, isolated by magnetic bead depletion of nonture of 4-48 h, very high expression on most monocytes was seen (Fig. 1A) which was not further regulated by IL-1 or monocytic cells. The purified monocyte fraction contained 96% CD14 ϩ cells, as analyzed by flow cytometry (not TNF-α (not shown). To exclude unspecific induction of CD137 on monocytes by isolation procedures, expression was also shown). Stimulation of purified monocytes with antibodies to CD137 also led to an induction of IL-8. However, in contrast analyzed in untreated peripheral blood, without density-gradient sedimentation, confirming constitutive expression of the to monocytes in cultures of PBMC, up-regulation of IL-8 protein was still seen after 20 h in all experiments (Fig. 3A) . receptor on monocytes (not shown).
The production of TNF-α by purified monocytes was also Induction of cytokine mRNA in primary monocytes by CD137 markedly induced at all time points (Fig. 3B) , comparable with the results obtained with monocytes in cultures of PBMC. To address the role of CD137 in monocyte function, monocytes derived from peripheral blood were cultured in the presence While induction of TNF-α was still seen after overnight culture, absolute cytokine levels had decreased by then (Fig. 3B) . of antibodies to CD137 and analyzed for cytokine expression. The purity of the isolated cell population was confirmed by
In addition to the induction of IL-8 and TNF-α, levels of IL-10 in monocytes cultured overnight with anti-CD137 were morphology and staining for CD68 identifying 82% of adherent cells as monocytes. The amount of mRNA/cDNA transcripts markedly reduced as compared to controls. IL-10 levels were decreased to 28% for monocytes in cultures of PBMC (mean of for TNF-α and IL-8 was determined by quantitative PCR, using a multispecific internal plasmid competitor. Stimulation of three experiments) and reduced to 44% for purified monocytes (mean of two experiments, Fig. 3C ). Reduction of IL-10 was monocytes via CD137 resulted in a 4-fold up-regulation of cDNA products of both cytokines, TNF-α and IL-8, compared already detectable after 6 h of cultures. to control antibodies (Fig. 2) . The equivalence point (1:1 ratio)
Competitive binding of antibody M121 to CD137 results in of target to competitor molecules for TNF-α was reached at inhibition of TNF-α induction mediated by mAb 4B4-1 2ϫ10 4 competitor molecules and was induced to 7.8ϫ10 4 molecules/40 ng cDNA by antibodies to CD137 as determined
To confirm a specific interaction with CD137 as the cause for the effects of the mAb 4B4-1, we tested the ability of mAb by densitometric analysis. For IL-8, signaling through CD137 induced 6.2ϫ10 5 molecules as compared to 1.56ϫ10 5 molec-M121, another mAb to CD137, to inhibit the induction of TNF-α release after cross-linking of CD137 by 4B4-1. Plates ules in the controls.
were precoated with isotype control or 4B4-1. In parallel, Regulation of cytokine protein expression by CD137 signaling isolated PBMC were pre-incubated with soluble M121 or isotype control. Cells were then kept on precoated antibodies In addition to mRNA levels, we further analyzed the regulation of cytokine protein synthesis by CD137. PBMC from healthy and after 20 h of culture supernatants were analyzed for TNF-α production. Pre-incubation of cells with mAb M121 donors were isolated and cultured in plastic dishes with immobilized mAb to CD137 or with control antibodies. Flow and subsequent culture on precoated 4B4-1 resulted in TNF-α levels comparable to control samples with precoated cytometry at the beginning, during and at the end of culture therefore increased production of TNF-α as demonstrated before.
Induction of B cell death by cross-linking of CD137 on monocytes
Since CD137 is reported to be involved in cell survival (12,17), we further studied viability in different cell populations of PBMC as regulated by anti-CD137. Cross-linking of CD137 with immobilized antibodies to CD137 resulted in a significant increase of B lymphocyte death ( Fig. 5A and Table 1 ). Cell death was analyzed by PI exclusion in CD19 ϩ cells on flow cytometry. After stimulation by CD137, it was detectable in up to 25% of B lymphocytes. Time course analysis of B cell death as induced by CD137 antibodies revealed maximal (Table 1) , we focused our further studies on B cell death M121, shown in the first column (mean Ϯ SD of three experiments).
although the rate of increase was similar in T and B cells.
Induction of B cell death by anti-CD137 is dependent on the presence of monocytes
isotype control and soluble M121 (Fig. 4) . Thus, mAb M121 specifically competes for binding to CD137 and prevents Since monocytes had been demonstrated as the only cells expressing CD137, the induction of B cell death by antibodies interaction of 4B4-1 with CD137 on monocytes. Pre-incubation of cells with soluble isotype control antibodies, however, to CD137 was most probably due to an interaction of B cells with monocytes. To confirm this hypothesis, cultures of cells allowed specific activation of CD137 by mAb 4B4-1 and PBMC from healthy donors were isolated and kept on culture surfaces precoated with immobilized antibodies as described in Fig.  3 . After 48 h of culture, cells were stained with antibodies to CD19, CD4 and CD8, and analyzed for the exclusion of PI by flow cytometry. Results are shown as mean Ϯ SD percentage of PI ϩ cells of four independent experiment (for CD8 three experiments were performed). Fig. 6 . Induction of B cell death is due to monocytes present in a Significant differences compared to controls (P Ͻ 0.005, by paired culture. PBMC, either untreated or completely depleted of monocytes Student's t-test).
by CD14 magnetic beads, were cultured with immobilized antibodies, as described in Fig. 4 (Fig. 6) . Depletion of monocytes led to abrogation of increased cell death by anti-CD137, showed increased cell death of B lymphocytes when incubated with anti-CD137 (Fig. 7) . This indicated that the presence confirming a specific interaction with monocytes as the most likely cause.
of monocytes and B cells was sufficient for the induction of
CD137-mediated induction of B cell apoptosis is dependent on cell-cell contact with monocytes
In the next set of experiments, we addressed the question whether induction of B cell apoptosis by cross-linking of CD137 on monocytes was caused by soluble factors or if a direct cell-cell contact of monocytes and B cells was necessary. PBMC isolated form individual donors were divided into two fractions of cells: purified monocytes and PBMC completely depleted of monocytes by CD14 antibodies. These two fractions were separated by a porous membrane with a pore size of 0.4 µm which only allows passage of soluble mediators (Fig. 8A) . The use of this membrane prevented direct cell-cell contact between B cells in the upper chamber and monocytes cultured on immobilized antibodies to CD137. As control, both fractions of cells were cultured together in parallel without separation by a membrane. As shown in Fig.  8(B) , CD137-induced apoptosis of B lymphocytes was not seen when monocytes and B cells were separated by a membrane. Culture of isolated cell fractions without separation by a membrane showed a CD137-mediated increase in B cell apoptosis (Fig. 8B ) similar to that demonstrated before (Figs 6 and 7).
Discussion
This study reports on the expression of CD137 on human , was not seen. This suggests maximal protein induction by contact-mediated mechanisms, as described for cell death and that cross-linking of CD137 on monocytes may other monocyte genes (32) . result in a direct interaction with B cells.
To functionally characterize CD137 in monocytes, we first examined the expression of the monocyte-derived cytokines CD137-induced cell death of B lymphocytes is due to TNF-α, IL-8 and IL-10 in cultures of PBMC and of purified apoptosis monocytes. TNF-α acts as a mediator of inflammation and is cytotoxic for many transformed cells (33) . Monocytes and In order to further characterize CD137-mediated cell death, isolated B lymphocytes and monocytes were co-cultured with macrophages are the main source of TNF-α (34). IL-8, which acts as a chemoattractant for neutrophils and is involved in immobilized antibodies to CD137. To discriminate between apoptosis and necrosis, we performed an enzymatic in situ inflammatory reactions, is also mainly produced by monocytes (35) . In our study, we found strong induction of TNF-α protein labeling technique of DNA strand breaks, a characteristic feature of apoptosis. Terminal deoxynucleotidyl transferase by antibodies to CD137 not only in PBMC cultures containing monocytes as the only cell population expressing CD137, but was used for the incorporation of FITC-labeled nucleotides to DNA strand breaks (TUNEL). After 20 h of culture with antialso in cultures of purified monocytes. The levels of TNF-α observed after cross-linking of CD137 on monocytes were CD137, cells were subjected to DNA strand break labeling, additionally stained for CD19 and analyzed by flow cytometry. similar to the concentrations of TNF-α reported for monocytes after CD40 stimulation (36) . In parallel, mRNA transcripts for Increased apoptosis was demonstrated in B cells cultured with antibodies to CD137, compared to isotype controls TNF-α were up-regulated in purified monocytes by signaling through CD137. The same stimulatory effect of CD137 cross- (Fig. 7) . The amount of apoptotic B cells induced by anti-CD137 was similar to levels with PI incorporation suggesting linking was also seen for IL-8 mRNA and protein, which were both markedly induced. However, in contrast to TNF-α, release apoptosis as the most likely reason for B cell death. of IL-8 was significantly inhibited in overnight cultures of may retain many characteristics of peripheral monocytes, since complete differentiation into macrophages by adher-PBMC by antibodies to CD137. Since this effect was not observed in cultures of purified monocytes, other cells such ence to plastic surfaces is found mostly after several more days of culture. as T or B lymphocytes present in the cultures and their interaction with monocytes could interfere with CD137 sigCross-linking of CD4 on monocytes leads to death of T and B lymphocytes which has been described as being due to naling and the synthesis of IL-8. Levels of IL-8 induced by CD137 reached~25% of those seen after stimulation with apoptosis mediated by the Fas-Fas ligand pathway (39) . Monocyte-dependent apoptosis of lymphocytes after activa-LPS, one of the strongest stimuli known for monocytes.
The increased production of IL-8 and TNF-α by monocytes tion by phorbol esters, however, does not seem to be mediated by this pathway (42). Recent experiments suggest that the after cross-linking of CD137 was accompanied by a marked reduction in IL-10 production in cultures of PBMC as well as apoptosis of B cells induced by cross-linking of CD137 on monocytes is also not caused by a Fas-Fas ligand interaction. in purified monocytes. IL-10 is well known as an important deactivating factor of monocyte function, e.g. by inhibiting Using CD4-cross-linking as a positive control for Fas-mediated apoptosis (39), monocyte-dependent apoptosis of B lymphoexpression of cytokines or by reducing expression of MHC class II molecules (37, 38) .
cytes induced by CD137 stimulation on monocytes was not inhibited by the antibody Nok-1 (not shown). This mAb is Taken together, these data demonstrating an increase of TNF-α and IL-8 and an inhibition of IL-10 production by known to efficiently block interaction of Fas with its ligand (39, 46) . monocytes argue for an association of CD137 with the proinflammatory program of monocytes.
Since a direct cell-cell contact between monocytes and B cells was necessary for CD137-mediated apoptosis, other In addition to the changes observed regarding the release of monocyte-derived cytokines, analysis of cell phenotypes cell surface molecules than Fas also containing a 'death domain' may be responsible for the apoptosis of B lymphoin cultures of PBMC stimulated with anti-CD137 antibodies revealed an increased rate of cell death in both T and B cytes seen in our experiments. The death receptors DR3, DR4, DR5 and DR6, also members of the TNF receptor family, lymphocytes. A high rate of~10% in spontaneous B cell death has already been reported by others (39, 40) . However, are potential candidates. All four are reported to induce apoptosis in lymphocytes (6-8, 10). In addition, transmemsince activation of CD137 drives up to 25% of B cells into apoptosis, this mechanism seems to be of biological brane expression of TNF-α could account for apoptosis via TNF receptor I in a cell-cell contact-dependent manner relevance.
Our findings further suggest that the increased B cell death (47,48). Whether the up-regulation of monocyte cytokines may increase susceptibility of B cells for apoptosis, as by CD137 stimulation is dependent on monocytes present in the culture. It is not mediated by soluble factors and requires described for CD4-mediated release of TNF-α and IFN-γ by monocytes (49), remains to be determined. Functional direct cell-cell contact. Monocyte-dependent cell death of lymphocytes has been reported by several other groups, e.g. specificity of the mAb 4B4-1, used for cross-linking of CD137 in this study, has been established earlier (50) and in our the induction of T cell death by phorbol myristate acetate treatment of monocytes (41,42) or after cross-linking of CD4 study was confirmed by competitive inhibition of 4B4-1 effects by another mAb to CD137. (39) . The latter mechanism is thought to be responsible for the accelerated apoptosis of T cells described in HIV infection
Little is known about potential human ligands of CD137. The available information is almost exclusively restricted to (43) . The differentiation of monocytes to macrophages in vitro by factors such as serum and the adherence of cells has data obtained from cell lines. Only one report which described the expression of CD137 ligand in different primary cells has been described (44, 45 well as apoptosis of B lymphocytes.
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